Brazil Diagnostic Labs Market
is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. This can be ascribed to the rising
prevalence of various chronic diseases such as cancer, cardiovascular diseases,
diabetes, among others. According to the global cancer observatory, in 2020,
around 592,212 new cancer cases were reported in Brazil, out of which 300,114
new cancer cases were reported in males while the number of new cancer cases
reported in females were around 292,098. Prostate Cancer, Breast Cancer,
Colorectum Cancer, Lung Cancer, and Thyroid Cancer were the fiver most
prevalent types of cancer in Brazil. Besides, growing geriatric population
in the country is further expected to support the market growth. Geriatric
population is susceptible to various kinds of communicable and non-communicable
diseases as result of which the demand for different diagnostic procedures has
significantly risen, thereby driving the growth of Brazil Diagnostic Labs
Market.
Diagnostic
tests form the fundamental component for the concept of health services. They
are the inseparable essential step towards guiding patient care.
Mandated
Access Helps the Brazilian Healthcare Industry
The
healthcare system in Brazil covers universal health strategies in which the
private health sector market is much relevant as it covers more than the public
health sector. The country has national health system, the Unified Health System
(SUS), established as a part of the 1988 federal constitution. The health
system is financed by through the public funds and the employee/employer
contributions to the National Social Security System (INSS). The SUS
provides access to the Brazilians via a mix of public and private providers out
of which approximately 77 % of the population utilizes the SUS totally, whereas
the rest 23% also has additional supplementary health schemes provided by the insurance
companies and health schemes providers. However, since the SUS has been
unable to reach Brazil’s entire population of 192 million, private health plans
have become increasingly popular offered as services through the private
insurance policies. According to the statistics, the spread of private
insurance among the total Brazilian population raised from 19.9% to 23.2% in
2018. This rise in insured public proportionally raises the use of
diagnostic services and labs, thereby supporting the growth of Brazil
Diagnostic Labs Market.
Growing
Number of Independent Labs and Clinical Chains
Presence
of significant number of independent labs and clinical chains has strengthened
the health services availability in distinct regions of Brazil and thereby
driving the diagnostic labs market growth. Public health laboratories are
organized in the National System of Public Health Laboratories (SISLAB), a set
of national laboratory networks for activities covering health, epidemiological
and environmental surveillance, and medical care. Each network is under the
responsibility of a government agency.
According
to the National Registry of Health Facilities in the Ministry of Health
(CNES/MS), by the end of June 2020, there were around 24,760 Therapeutic
Diagnosis Support Services (SADTs) in Brazil. In
the country there is at least one SADT unit for 3,466 cities, with respect to
62% of municipalities therein operating within hospitals, clinics and other health
facilities. Most of these are provided by private organizations and a
small proportion by the public sector.
Frequency
of Tests and Assessments for Monitoring Individuals with Diabetes
According
to report published by the Brazilian Society of Diabetes (Sociedade Brasileira
de Diabetes - SBD), in 2021 the incidence of diabetes in Brazil was 7.6% of the
population (approximately 16 million people).
Brazil holds the fifth position in the number of diabetes cases, after China,
India, the United States and Pakistan. Diabetes is the third leading cause of mortality
in the country, with cardiovascular diseases and cancer being number one and
two, respectively. This in turn creates the need for diagnosing and doing
regular monitoring for diabetes in the country thereby fostering the growth of
Brazil Diagnostic Labs Market.
Recent
Developments
According
to a report published, in 2019, DASA Labs, the biggest diagnostic company in
Brazil, made a step towards integrating health care by investing in the acquisition
of hospitals. After Rede D’Or acquisition, it became the second largest
hospital group in the country. Similarly, Fleury, recently merged with Hermes Pardini,
another leader in the Brazil diagnostics. Meanwhile Fleury along with the
integrated healthcare, it has also acquired medical clinics. All these
strategies followed by key players operating in the industry such as mergers
& acquisitions, collaborations & partnerships, investments, and
expansions not only help them in staying competitive and have an edge over
other players operating in the market but also support the growth of Brazil
diagnostic labs market.
Rising
Geriatric Population
Brazil
holds 6th position among the world’s populated countries after
China, India, United States, Indonesia and Pakistan. The country has been going
through an expeditious demographic change, with near about 10% of the aged
population over 65 years. The growing ageing population in Brazil is
estimated to experience an enormous growth, as the country’s population is
supposed to shift the ageing population of 45 and older are predicted to
represent 52% of the total by 2050, versus 33% in 2020.
The
increasing disease prevalence among the aged population makes them more dependent
on the diagnostic labs every now and then and thereby boost the market growth.
Download Free Sample Report
Market
Segmentation
Brazil
Diagnostic Labs Market is segmented into Provider Type, test type, end users, and
region. Based on product type, the market can be segmented into Hospital Based
Diagnostic Labs, Diagnostic Chains and Stand-Alone Diagnostic Labs. Depending on the Test
type, the market can be segmented into Pathology and Radiology. Based on end
users, the market can be differentiated into Walk-ins, Referrals and Corporate Clients.
Market Players
DASA labs, Quest Diagnostics
Incorporated, SYNLAB-Solutions in Diagnostics, Grupo Fleury, Hospital Israelita
Albert Einstein, Alliar, Boris Berenstein Diagnostic Center, Clinica da Imagem
do Tocantis, Abramed and Hermes Pardini, etc. are some of the leading players
operating in the Brazil Diagnostic Labs Market.
Attribute
|
Details
|
Base Year
|
2022
|
Historic
Data
|
2018 – 2021
|
Estimated
Year
|
2023
|
Forecast
Period
|
2024 – 2028
|
Quantitative
Units
|
Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
|
Report Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
Segments Covered
|
·
By Provider Type
·
By Test Type
·
By End User
·
By Region
|
Regional
scope
|
South-Central,
South-West, East, North-East, North-West, North
|
Country
scope
|
Brazil
|
Key
companies profiled
|
Dasa Labs,
Quest Diagnostics Incorporated, SYNLAB-Solutions in Diagnostics, Grupo
Fleury, Hospital Israelita Albert Einstein, Alliar, Boris Berenstein
Diagnostic Center, Clinica da Imagem do Tocantis, Abramed, Hermes Pardini.
|
Customization
scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
Pricing and
purchase options
|
Avail
customized purchase options to meet your exact research needs. Explore purchase options
|
Delivery
Format
|
PDF and Excel through Email (We can also provide the editable
version of the report in PPT/Word format on special request)
|
Report Scope:
In this report, the global Brazil Diagnostic Labs Market has been segmented into the following
categories, in addition to the industry trends which have also been detailed
below:
·
Brazil
Diagnostic Labs Market, By Provider Type:
o
Hospital Based Diagnostic Labs
o
Diagnostic Chains
o Stand Alone Diagnostic Labs
·
Brazil
Diagnostic Labs Market, By Test Type:
o
Pathology
o
Radiology
·
Brazil
Diagnostic Labs Market, By End User:
o
Walk-ins
o Referrals
o Corporate Clients
·
Brazil Diagnostic Labs
Market, By Region
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in the Brazil Diagnostic Labs Market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following customization
options are available for the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
Global Brazil Diagnostic Labs Market is
an upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]